Melanovus Oncology (Assets) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Melanovus Oncology (Assets) General Information

Description

Seven pre-clinical compounds. These compounds are useful for the treatment of melanoma and other cancers.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Corporate Office
  • FL
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Melanovus Oncology (Assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Melanovus Oncology (Assets)‘s full profile, request access.

Request a free trial

Melanovus Oncology (Assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Melanovus Oncology (Assets)‘s full profile, request access.

Request a free trial

Melanovus Oncology (Assets) FAQs

  • Where is Melanovus Oncology (Assets) headquartered?

    Melanovus Oncology (Assets) is headquartered in FL.

  • What industry is Melanovus Oncology (Assets) in?

    Melanovus Oncology (Assets)’s primary industry is Buildings and Property.

  • Is Melanovus Oncology (Assets) a private or public company?

    Melanovus Oncology (Assets) is a Private company.

  • What is the current valuation of Melanovus Oncology (Assets)?

    The current valuation of Melanovus Oncology (Assets) is 00000.

  • What is Melanovus Oncology (Assets)’s current revenue?

    The current revenue for Melanovus Oncology (Assets) is 000000.

  • Who are Melanovus Oncology (Assets)’s investors?

    Melanovus Oncology has invested in Melanovus Oncology (Assets).

  • When was Melanovus Oncology (Assets) acquired?

    Melanovus Oncology (Assets) was acquired on 09-Jan-2015.

  • Who acquired Melanovus Oncology (Assets)?

    Melanovus Oncology (Assets) was acquired by Cipher Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »